Updated results from KEYNOTE-426 for metastatic kidney cancer

Bookmark and Share
Published: 12 Jun 2020
Views: 481
Dr Elizabeth Plimack - Fox Chase Cancer Center, Philadelphia, USA

Dr Elizabeth Plimack talks to ecancer in an online interview for the ASCO virtual meeting 2020 about the KEYNOTE-426 study.

She outlines the trial design and explains the ongoing development of the study.

Dr Plimack discusses the updated results and maintained benefit of this combination.